FDA Inspection
AGC Biologics, Inc.AGC Biologics, Inc. – FDA Inspection, Apr 20, 2017
Record Details
This FDA Inspection record concerns AGC Biologics, Inc., with an inspection on April 20, 2017, issued by the Seattle District Office, covering biologics.
View Company Profile
ID · fe42acfd-0e4e-4d25-b2fc-2bb6d3a5771a
Inspection Facts
- Inspection number
- 1016289
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of AGC Biologics, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| April 18, 2025 | Not classified | Seattle District Office | |
| March 27, 2024 | Not classified | Seattle District Office | |
| February 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 15, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for AGC Biologics, Inc.
- FDA Inspection 1265749 - 2025-04-18
- FDA Inspection 1231895 - 2024-03-27
- FDA Inspection 1197098 - 2023-02-10
- FDA Inspection 1149254 - 2021-07-23
- FDA Inspection 1109813 - 2018-10-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.